Yoo Ri Kim
Overview
Explore the profile of Yoo Ri Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeong H, Yoon N, Kim Y, Lee K, Park H
J Korean Med Sci
. 2025 Jan;
40(1):e2.
PMID: 39763307
Background: The ionic mechanism underlying Brugada syndrome (BrS) arises from an imbalance in transient outward current flow between the epicardium and endocardium. Previous studies report that artemisinin, originally derived from...
2.
Song H, Kim Y, Lee S, Nam H, Kim H, Kyoung D, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(9):303.
PMID: 39077692
Background And Objectives: Type 2 diabetes (T2D) is an independent risk factor for the development of atrial fibrillation (AF). Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have recently been shown to decrease the...
3.
Ly N, Kim Y, Lee K, Yoon N, Park H
Front Cardiovasc Med
. 2024 Apr;
11:1334096.
PMID: 38559671
Background: Brugada syndrome (BrS) is a channelopathy that can lead to sudden cardiac death in the absence of structural heart disease. Patients with BrS can be asymptomatic or present with...
4.
Jeon S, Lee N, Lee K, Ha M, Kim C, Kim Y, et al.
Korean J Intern Med
. 2024 Jan;
39(3):458-468.
PMID: 38287499
Background/aims: The SAMe-TT2R2 score is used for assessing anticoagulation control (AC) quality with warfarin. However, it is hard to apply SAMe-TT2R2 score in Asian patients with atrial fibrillation (AF), because...
5.
Cho J, Lee K, Kim Y, Kim S, Gwak J, Cho E, et al.
Clin Appl Thromb Hemost
. 2023 Apr;
29:10760296231171081.
PMID: 37082789
Anticoagulation with warfarin in Asian patients with atrial fibrillation (AF) often has been decreased as an international normalized ratio (INR) of prothrombin time 1.6-2.6 due to fear of bleeding, although...
6.
Cho M, Kang D, Oh Y, Lee C, Choi E, Lee J, et al.
Am Heart J
. 2022 Feb;
247:123-131.
PMID: 35149036
Background: Anticoagulants are the standard therapy for patients with atrial fibrillation (AF) and antiplatelet therapy for those with coronary artery disease (CAD). However, compelling clinical evidence is still lacking regarding...
7.
Shin D, Kim S, Kim Y
Rev Cardiovasc Med
. 2022 Jan;
23(1):2.
PMID: 35092194
Background: The use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (AF) has been increasing. Accordingly, the combined use of antiplatelet agents (APT) and NOAC...
8.
Liu A, Kim Y, OConnell J
Ann Tour Res
. 2022 Jan;
92:103347.
PMID: 35013629
[This corrects the article DOI: 10.1016/j.annals.2021.103298.].
9.
Kim J, Rhee M, Kim C, Kim Y, Do U, Kim J, et al.
J Clin Hypertens (Greenwich)
. 2021 Oct;
23(11):1965-1974.
PMID: 34699680
The authors developed and validated a diagnostic algorithm using the optimal upper and lower cut-off values of office and home BP at which ambulatory BP measurements need to be applied....
10.
Kim Y, Liu A
Tour Manag
. 2021 Oct;
88:104416.
PMID: 34629610
With the tourism and hospitality sector reopening post-lockdown of COVID-19, the recovery of customers' purchase intentions is essential to reboot the sector. This study aims to examine the relationship between...